European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis.

< Back to ILB Patrimony
Authors
  • TZOGANI Kyriaki
  • YU Yang
  • MEULENDIJKS Didier
  • HERBERTS Carla
  • HENNIK Paula
  • VERHEIJEN Remy
  • WANGEN Torunn
  • DAHLSENG HAKONSEN Gro
  • KAASBOLL Torny
  • DALHUS Marianne
  • BOLSTAD Bjorg
  • SALMONSON Tomas
  • GISSELBRECHT Christian
  • PIGNATTI Francesco
Publication date
2019
Publication type
Journal Article
Summary No summary available.
Publisher
Elsevier BV
See the publication
Topics of the publication
Themes detected by scanR from retrieved publications. For more information, see https://scanr.enseignementsup-recherche.gouv.fr